Ce scientifique démonte l’industrie cosmétique : Ce qu’il a découvert en laboratoire !

The core thesis is straightforward: cosmetics should be judged by measurable efficacy, not brand prestige, texture, or price. Jean-Michel Caram says the luxury segment often “vend du rêve trop cher,” and argues that many mass-market products are weak because they rely on very low ingredient concentrations, pleasant textures, and placebo-like usage patterns rather than meaningful actives. His preferred framework is combination chemistry: the right ingredients, at high enough concentration, with enough penetration into the skin, and then measured over time. He repeatedly stresses prevention over correction — act before wrinkles are established. A major thread is the contrast between his scientific background and how the beauty industry traditionally operates. …

1. He argues cosmetics should be evaluated by measurable efficacy, not luxury branding or packaging.
2. The key variables for skin products are ingredient selection, concentration, penetration, and prevention.
3. He believes lifestyle and environmental stress account for a large share of visible aging.
4. His concept of “beautiful longevity” focuses on staying well and presentable rather than chasing extreme life extension.
5. He sees AI, skin measurement, and hyper-personalization as the future of beauty.
6. He ties business success to risk-taking, hard work, patience, and discipline.
7. He presents Lebanon, religion, and family as central identity anchors.
8. A recurring theme is that most industries, including media and beauty, contain a lot of hype and weak claims.

• He makes very strong efficacy claims about concentration and product superiority, but provides no transparent clinical details, published study references, or effect sizes in the transcript.
• The statement that mass-market products “use placebo” is rhetorically sharp but not rigorously demonstrated here.
• He generalizes from one twin study to broad conclusions about aging; the sample size and methodology are not explained.
• The claim that collagen cannot help unless gene pathways are targeted is presented too absolutely and ignores nuance across delivery methods and evidence tiers.
• He frames luxury skincare as not meaningfully better than mid-tier products, but this may depend heavily on product class and active formulation.
• Several statements about AI, media death, and national character are broad and mostly anecdotal rather than evidenced.